Atlas Trials

Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs

Clinical trial NCT03346642 · UNKNOWN

Trial details

NCT number
NCT03346642
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Primary Mediastinal Large B-cell Lymphoma
Start date
2017-05-01
Primary completion
2019-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.